×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
CLDI – calidi biotherapeutics, inc. (US:AMEX)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
CLDI
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
3/27
04:25 pm
cldi
Calidi Biotherapeutics Reports Fourth Quarter and Full-Year 2025 Financial Results and Recent Operational Highlights
Low
Report
Calidi Biotherapeutics Reports Fourth Quarter and Full-Year 2025 Financial Results and Recent Operational Highlights
3/24
08:10 am
cldi
Calidi Biotherapeutics Announces Partnership with Avance Clinical to Facilitate Australian Regulatory Approval and Accelerate Initiation of CLD-401 Clinical Trials [Yahoo! Finance]
Medium
Report
Calidi Biotherapeutics Announces Partnership with Avance Clinical to Facilitate Australian Regulatory Approval and Accelerate Initiation of CLD-401 Clinical Trials [Yahoo! Finance]
3/24
08:00 am
cldi
Calidi Biotherapeutics Announces Partnership with Avance Clinical to Facilitate Australian Regulatory Approval and Accelerate Initiation of CLD-401 Clinical Trials
High
Report
Calidi Biotherapeutics Announces Partnership with Avance Clinical to Facilitate Australian Regulatory Approval and Accelerate Initiation of CLD-401 Clinical Trials
3/12
08:00 am
cldi
Calidi Biotherapeutics Presents its Innovative and Scalable Manufacturing Process for CLD-401 at the 9th Annual Bioprocessing Summit; FDA Feedback Support Company’s Approach to Manufacturing
Medium
Report
Calidi Biotherapeutics Presents its Innovative and Scalable Manufacturing Process for CLD-401 at the 9th Annual Bioprocessing Summit; FDA Feedback Support Company’s Approach to Manufacturing
3/9
09:31 pm
cldi
Calidi Biotherapeutics Announces Closing of $6.0 Million Underwritten Public Offering and Full Exercise of Underwriters' Over-Allotment Option [Yahoo! Finance]
Medium
Report
Calidi Biotherapeutics Announces Closing of $6.0 Million Underwritten Public Offering and Full Exercise of Underwriters' Over-Allotment Option [Yahoo! Finance]
3/9
08:50 pm
cldi
Calidi Biotherapeutics Announces Closing of $6.0 Million Underwritten Public Offering and Full Exercise of Underwriters’ Over-Allotment Option
Medium
Report
Calidi Biotherapeutics Announces Closing of $6.0 Million Underwritten Public Offering and Full Exercise of Underwriters’ Over-Allotment Option
3/6
08:51 am
cldi
Calidi Biotherapeutics Announces Pricing of $5.2 Million Underwritten Public Offering [Yahoo! Finance]
High
Report
Calidi Biotherapeutics Announces Pricing of $5.2 Million Underwritten Public Offering [Yahoo! Finance]
3/6
08:30 am
cldi
Calidi Biotherapeutics Announces Pricing of $5.2 Million Underwritten Public Offering
High
Report
Calidi Biotherapeutics Announces Pricing of $5.2 Million Underwritten Public Offering
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
3/27
05:01 pm
cldi
Form 10-K Calidi Biotherapeutics, For: Dec 31
Low
Report
Form 10-K Calidi Biotherapeutics, For: Dec 31
3/27
04:58 pm
cldi
Form 8-K Calidi Biotherapeutics, For: Mar 27
Low
Report
Form 8-K Calidi Biotherapeutics, For: Mar 27
3/11
05:09 pm
cldi
Form 8-K Calidi Biotherapeutics, For: Mar 05
Low
Report
Form 8-K Calidi Biotherapeutics, For: Mar 05
3/9
01:15 pm
cldi
Form SCHEDULE 13D Calidi Biotherapeutics, Filed by: Gavrilov Ognian Anguelov
Low
Report
Form SCHEDULE 13D Calidi Biotherapeutics, Filed by: Gavrilov Ognian Anguelov
3/9
06:02 am
cldi
Form 424B5 Calidi Biotherapeutics,
Low
Report
Form 424B5 Calidi Biotherapeutics,
3/6
06:01 am
cldi
Form 424B5 Calidi Biotherapeutics,
High
Report
Form 424B5 Calidi Biotherapeutics,
3/5
10:00 pm
cldi
Form S-3MEF Calidi Biotherapeutics,
High
Report
Form S-3MEF Calidi Biotherapeutics,
2/10
02:08 pm
cldi
Form SCHEDULE 13G/A Calidi Biotherapeutics, Filed by: Lincoln Alternative Strategies LLC
Low
Report
Form SCHEDULE 13G/A Calidi Biotherapeutics, Filed by: Lincoln Alternative Strategies LLC
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: